CD8A and COVID-19: Despite overall lymphopenia in our population of patients with COVID-19, consistently described in earlier studies (Wiersinga et al., 2020), we report a proportional increase in cells that resemble CD8 EMRA T cells with a pronounced cytotoxic transcriptional signature.